ORGO
OrganogenesisFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
Composite grade F from latest DB weights. Momentum 13.6 / Value 55.6
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +1.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
14
Value
56
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $8.00
Why
Momentum14 · Δ7d -
Value56 · Δ7d +1.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
14
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
56
48% active weight
Current posture
7d trendImproving
Δ7d
+1.1
Δ21d
+1.5
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 13.6 / Value 55.6
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$288.23M
Beta
1.47
Shares Out
126.91M
P/E (TTM) · Derived
14.4
P/S (TTM)
1.20
P/FCF (TTM)
134.02
Rev YoY
+31.0%
EPS YoY
+20.6%
Gross Margin
+74.5%
Op Margin
-1.8%
Net Debt
-$133.68M
Current Ratio
3.32
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology